drugset / Trial / NCT00421083

Efficacy and Safety of Tadalafil in Subjects With Erectile Dysfunction Caused by Spinal Cord Injury

NCT00421083

Phase 3 Completed 180 enrolled Eli Lilly and Company ICOS Corporation · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a study of the efficacy and safety of on-demand dosing of tadalafil or placebo administered for 12 weeks to men with erectile dysfunction caused by spinal cord injury.

Timeline

Start
2004-09
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule